What 2026 holds for biotech and Quality - with Jon Voss and Ed Armstrong

Podcast: Let's Talk Quality · Hemish Ilangaratne

Opublikowano: 2026-02-10

In today’s episode, Hemish was joined by Ed Armstrong and Jon Voss, two Quality leaders who’ve both worked across early-stage, clinical, and complex biotech environments. Ed and Jon share what they’re seeing on the ground - from funding pressure and modality shifts, to how regulators are engaging, and where Quality leaders are gaining (or losing) influence. They talk about the following: The current state of pharma and biotech, and whether the market has really bottomed outWhich modalities and parts of the market feel resilient, and which are still strugglingHow FDA leadership change...